Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Pediatr. 2016 Nov 3;181:37–41.e1. doi: 10.1016/j.jpeds.2016.10.033

Table 5.

Overall mortality and frequency of CHDs and adjusted odds ratios for mortality compared to very/extremely premature infants without CHD (n=6973)

Mortality

% died (95% CI) Adjusted OR (95% CI)
DORV (n=43, 0.6%) 52.6 (29.8, 75.4) 17.5 (6.0, 51.0)
Pulmonary atresia (n=35, 0.6%) 30.3 (9.1, 51.5) 13.2 (4.1, 42.3)
Non-HLHS single ventricle (n=48 0.7%) 29 (13.1, 44.6) 10.5 (4.7, 23.3)
HLHS (n=207, 3.0%) 31.1 (23.9, 38.2) 9.8 (6.4, 15.1)
Tetralogy of Fallot (n=96, 1.4%) 26.4 (16.9, 35.9) 7.1 (4.0, 12.4)
AV canal defect (n=42, 0.6%) 25.5 (10.7, 40.3) 6.6 (2.2, 19.8)
Coarctation (n=139, 2.0%) 11.6 (4.3, 19.0) 2.7 (1.2, 6.0)
VSD (n=1059, 15.2%) 5.2 (3.4, 7.0) 0.8 (0.5, 1.2)
Interrupted aortic arch (n=47, 0.7%) 12.8 (1.0, 24.7) 2.9 (0.8, 11.0)
ASD (n=4834, 69.3%) 4.3 (3.5, 5.1) 0.6 (0.5, 0.7)
Pulmonary stenosis (n=323, 4.6%) 2.8 (0.8, 4.8) 0.5 (0.2, 0.9)
Truncus arteriosus+ (n=22, 0.3%) 67.4 (5.7, 59.4) -
TAPVR+ (n=19, 0.3%) 35.3 (5.7, 65.0) -
Aortic stenosis+ (n=17, 0.2%) 19.7 (0.0, 43.5) -
TGA+ (n=24, 0.3%) 19.0 (0.2, 37.8) -
Ebstein anomaly+ (n=17, 0.2%) 17.2 (13.0, 80.9) -
Any severe defect (n=758, 10.9%) 26.3 (22.7, 29.9) 7.5 (5.9, 9.6)
No congenital heart defect 5.3 (4.9, 5.8) Reference
*

Adjusted for GA, sex, race, SGA, Downs syndrome, hospital teaching status, year

+

Regression analysis was not performed for defects with sample size < 30